Incidental Regression of a Suspected Pancreatic Intraductal Papillary Mucinous Neoplasm after Nontarget Embolization

J Vasc Interv Radiol. 2016 Jun;27(6):922-3. doi: 10.1016/j.jvir.2015.12.758. Epub 2016 Jun 3.

Authors

Jeffrey Forris Beecham Chick¹, James X Chen¹, Shelby J Bennett¹, Nikunj Rashmikant Chauhan¹, Shilpa N Reddy¹, Terence Gade¹, Micah M Watts¹, Gregory J Nadolski¹

Affiliation

¹ Department of Radiology, Division of Interventional Radiology, Hospital of the University of Pennsylvania, Perelman School of Medicine, 1 Silverstein, 3400 Spruce Street, Philadelphia, PA 19104.

PMID: 27287972
DOI: 10.1016/j.jvir.2015.12.758

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Angiography
Antibiotics, Antineoplastic / administration & dosage
Carcinoma, Hepatocellular / diagnostic imaging
Carcinoma, Hepatocellular / pathology
Carcinoma, Hepatocellular / therapy*
Carcinoma, Hepatocellular / virology
Chemoembolization, Therapeutic*
Doxorubicin / administration & dosage
Endoscopy, Digestive System
Humans
Incidental Findings*
Liver Neoplasms / diagnostic imaging
Liver Neoplasms / pathology
Liver Neoplasms / therapy*
Liver Neoplasms / virology
Magnetic Resonance Imaging
Male
Neoplasms, Cystic, Mucinous, and Serous / diagnostic imaging
Neoplasms, Cystic, Mucinous, and Serous / pathology
Neoplasms, Cystic, Mucinous, and Serous / therapy*
Neoplasms, Multiple Primary*
Pancreatic Neoplasms / diagnostic imaging
Pancreatic Neoplasms / pathology
Pancreatic Neoplasms / therapy*
Predictive Value of Tests
Time Factors
Treatment Outcome

Substances

Antibiotics, Antineoplastic
Doxorubicin